Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

565 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
CPT-11 (irinotecan) in the treatment of colorectal cancer.
Armand JP, Ducreux M, Mahjoubi M, Abigerges D, Bugat R, Chabot G, Herait P, de Forni M, Rougier P. Armand JP, et al. Among authors: ducreux m. Eur J Cancer. 1995 Jul-Aug;31A(7-8):1283-7. doi: 10.1016/0959-8049(95)00212-2. Eur J Cancer. 1995. PMID: 7577037 Review.
5-Fluorouracil (5-FU) continuous intravenous infusion compared with bolus administration. Final results of a randomised trial in metastatic colorectal cancer.
Rougier P, Paillot B, LaPlanche A, Morvan F, Seitz JF, Rekacewicz C, Laplaige P, Jacob J, Grandjouan S, Tigaud JM, Fabri MC, Luboinski M, Ducreux M. Rougier P, et al. Among authors: ducreux m. Eur J Cancer. 1997 Oct;33(11):1789-93. doi: 10.1016/s0959-8049(97)00175-5. Eur J Cancer. 1997. PMID: 9470834 Clinical Trial.
Oxaliplatin in colorectal cancer: an overview.
Armand JP, Boige V, Raymond E, Fizazi K, Faivre S, Ducreux M. Armand JP, et al. Among authors: ducreux m. Semin Oncol. 2000 Oct;27(5 Suppl 10):96-104. Semin Oncol. 2000. PMID: 11049040 Review. No abstract available.
Factors predicting for efficacy of oxaliplatin in combination with 5-fluorouracil (5-FU)+/-folinic acid (FA) in a compassionate-use cohort of 370 5-FU-resistant advanced colorectal cancer (CRC) patients.
Bensmaïne, de Gramont A, Brienza S, Marty M, Lévi F, Ducreux M, François E, Gamelin E, Bleiberg H, Bleuzen P, Simon J, Cvitkovic E. Bensmaïne, et al. Among authors: ducreux m. Eur J Cancer. 2000 Dec;36(18):2335-43. doi: 10.1016/s0959-8049(00)00305-1. Eur J Cancer. 2000. PMID: 11094307 Clinical Trial.
565 results